These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


456 related items for PubMed ID: 22819824

  • 1. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI.
    FEBS Lett; 2012 Sep 21; 586(19):3309-16. PubMed ID: 22819824
    [Abstract] [Full Text] [Related]

  • 2. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.
    Assal RA, El Tayebi HM, Hosny KA, Esmat G, Abdelaziz AI.
    Mol Med Rep; 2015 Jul 21; 12(1):645-50. PubMed ID: 25739014
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
    Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y, Zheng X.
    Oncol Rep; 2012 Aug 21; 28(2):701-6. PubMed ID: 22664953
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.
    World J Gastroenterol; 2016 Jun 21; 22(23):5364-73. PubMed ID: 27340352
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
    Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L, Tian Q, Zha R, Zhan R, He X.
    Carcinogenesis; 2011 Nov 21; 32(11):1641-7. PubMed ID: 21890460
    [Abstract] [Full Text] [Related]

  • 6. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
    Shi X, Teng F.
    Mol Cell Biochem; 2015 Oct 21; 408(1-2):283-93. PubMed ID: 26160280
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.
    FEBS J; 2015 Feb 21; 282(3):579-94. PubMed ID: 25475121
    [Abstract] [Full Text] [Related]

  • 8. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
    Tan S, Li R, Ding K, Lobie PE, Zhu T.
    FEBS Lett; 2011 Jul 21; 585(14):2229-34. PubMed ID: 21658389
    [Abstract] [Full Text] [Related]

  • 9. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, Jiang J.
    Biochem Biophys Res Commun; 2012 Nov 30; 428(4):525-31. PubMed ID: 23068095
    [Abstract] [Full Text] [Related]

  • 10. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.
    J Gastroenterol Hepatol; 2011 Nov 30; 26(11):1630-7. PubMed ID: 21557766
    [Abstract] [Full Text] [Related]

  • 11. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang Y, Zhao J, McCrae MA, Zhuang H.
    Cancer; 2012 May 01; 118(9):2431-42. PubMed ID: 21989846
    [Abstract] [Full Text] [Related]

  • 12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G, Lin Y, Zhang H, Wu D.
    Biochem Biophys Res Commun; 2015 Jul 31; 463(3):315-21. PubMed ID: 26022123
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun 31; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 14. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
    Huang N, Lin J, Ruan J, Su N, Qing R, Liu F, He B, Lv C, Zheng D, Luo R.
    FEBS Lett; 2012 Mar 23; 586(6):884-91. PubMed ID: 22449976
    [Abstract] [Full Text] [Related]

  • 15. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT, Ching AK, Chan AW, Wong QW, Wong CK, To KF, Wong N.
    Carcinogenesis; 2012 Jun 23; 33(6):1134-41. PubMed ID: 22431718
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal.
    Luo L, Ye G, Nadeem L, Fu G, Yang BB, Honarparvar E, Dunk C, Lye S, Peng C.
    J Cell Sci; 2012 Jul 01; 125(Pt 13):3124-32. PubMed ID: 22454525
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.
    J Hepatol; 2015 Oct 01; 63(4):874-85. PubMed ID: 25998163
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF, Dai H, Ou Q, Zuo GQ, Liu CA.
    Tumour Biol; 2016 May 01; 37(5):5885-95. PubMed ID: 26589417
    [Abstract] [Full Text] [Related]

  • 19. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH, Shan H, Li D, Zhou B, Pang PF.
    Cell Biochem Funct; 2017 Mar 01; 35(2):98-104. PubMed ID: 28261837
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells.
    Zhang Y, Gong W, Dai S, Huang G, Shen X, Gao M, Xu Z, Zeng Y, He F.
    Mol Cancer Res; 2012 Apr 01; 10(4):516-22. PubMed ID: 22446874
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.